6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
8m ago	ProWood TrueFrame Joist Now Available Across Northeast, South Atlantic
8m ago	Parker to Acquire CIRCOR’s Commercial and Defense Aerospace Business
8m ago	Toll Brothers Announces Cedar Terrace Community Now Open in Chantilly, Virginia
9m ago	When Blood Compatibility Becomes a Pregnancy Risk
9m ago	Tony and Grammy Award-Winning Leslie Odom, Jr. to Headline Blackbaud's bbcon 2026 Social Impact Tech Conference

About

4.60USD-0.01 -0.22%

Closed • Updated at 13:56 GMT+00:00

Market Cap$8.84M

Volume2.6K

Beta0.54

RSI47.01

Gross Margin83.15%

Health TechnologyPharmaceuticals: Major

Bolt Biotherapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Bolt Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update

Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027

Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Community Chat

Ask AI